Oyster Point Pharma Inc (OYST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OYST | AMGN | BMY | VRTX | GILD |
| Company | Oyster Point Pharma Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 11.16 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 11.20 | 290.21 | 58.38 | 455.43 | 89.94 |
| Low | 11.12 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 11.17 | 289.95 | 58.23 | 450.96 | 89.60 |
| Change | +0.02 | +2.08 | +0.35 | -0.27 | +0.97 |
| % Change | +0.18% | +0.72% | +0.60% | -0.06% | +1.09% |
| Volume | 2,088,200 | 1,350,265 | 3,102,976 | 637,782 | 1,553,300 |
| 20-Day Average Volume | 306,230 | 2,806,995 | 12,173,468 | 1,301,151 | 7,399,830 |
| Previous Close | 11.15 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 11.13 | 307.38 | 55.92 | 479.22 | 90.89 |
| 20-Day Raw Stochastic | 76.47% | 25.72% | 69.42% | 6.51% | 29.25% |
| 20-Day Relative Strength | 66.58% | 35.87% | 60.74% | 40.79% | 53.73% |
| Weighted Alpha | -44.20 | +1.54 | +26.09 | +17.92 | +26.20 |
| Today's Opinion | 100% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 100% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 100% Buy | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 12/22/22 | -2.30% since 11/14/24 | -0.44% since 11/14/24 | -7.02% since 11/14/24 | -2.48% since 11/14/24 |
| Low | 11.04 on 12/23/22 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.13 on 11/21/24 | 86.08 on 11/19/24 |
| High | 11.20 on 12/30/22 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | -0.09% since 11/30/22 | -8.72% since 10/21/24 | +11.75% since 10/21/24 | -5.88% since 10/21/24 | +4.10% since 10/21/24 |
| Low | 11.04 on 12/23/22 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.13 on 11/21/24 | 85.60 on 10/22/24 |
| High | 11.25 on 12/01/22 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +98.75% since 09/30/22 | -12.16% since 08/21/24 | +20.24% since 08/21/24 | -7.43% since 08/21/24 | +19.57% since 08/21/24 |
| Low | 5.17 on 10/03/22 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.13 on 11/21/24 | 75.35 on 08/22/24 |
| High | 11.83 on 11/07/22 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +157.97% since 06/30/22 | -8.18% since 05/21/24 | +37.79% since 05/21/24 | +1.81% since 05/21/24 | +33.50% since 05/21/24 |
| Low | 4.20 on 07/07/22 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 11.83 on 11/07/22 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 299,847 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 26,844 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 24,540,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -100,660,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 5,590,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -36,750,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 1.35 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.37 on 11/10/22 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 02/23/23 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.57 | 49.77 | 0.00 | 19.81 |